Headlands Technologies LLC Halozyme Therapeutics, Inc. Transaction History

Headlands Technologies LLC

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 02, 2024	BUY	$33.32 - $42.1 $53,745 - $67,907	1,613 Added 1068.21%	1,764 $65,000
Q3 2023 Nov 09, 2023	SELL	$36.46 - $44.03 $254,126 - $306,889	-6,970 Reduced 97.88%	151 $5,000
Q2 2023 Aug 03, 2023	BUY	$30.28 - $38.74 $215,623 - $275,867	7,121 New	7,121 $256,000

542

125M

294K

180K

Ticker HALO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 139,288,992
Market Cap $7.35B
Description
Halozyme Therapeutics, Inc. operates as a biopharma technology platform company in the United States, Switzerland, Ireland, Belgium, Japan, and internationally. The company's products are based on the ENHANZE drug delivery technology, a patented recombinant human hyaluronidase enzyme (rHuPH20) that enables the subcutaneous delivery of injectable...

Get notified when there are updates to the investment portfolio of Headlands Technologies LLC, based on Form 13F filings with the SEC.

Stay updated on Headlands Technologies LLC with notifications on news.